Xbaren 150 Tablet SR contains Oxcarbazepine 150 mg, an antiepileptic agent primarily used in the management of partial seizures with or without secondary generalization in adults and children. Oxcarbazepine acts by stabilizing hyperexcited neural membranes, inhibiting repetitive neuronal firing, and reducing the propagation of seizure activity through modulation of voltage-sensitive sodium channels. The sustained-release formulation ensures a gradual release of the active ingredient, promoting steady plasma concentrations and improved therapeutic efficacy while minimizing peak-related adverse effects. Xbaren 150 Tablet SR is indicated as monotherapy or adjunctive therapy for epilepsy and may also be considered in the treatment of bipolar disorder as an off-label use. Common side effects include dizziness, somnolence, headache, nausea, and hyponatremia; therefore, periodic monitoring of serum sodium levels is recommended during therapy. Caution is advised in patients with hepatic or renal impairment, and dose adjustments may be necessary. Oxcarbazepine has potential drug interactions, particularly with other antiepileptic drugs, oral contraceptives, and diuretics, necessitating careful assessment before initiation. Patients should be counseled on adherence to prescribed dosing schedules and advised to report any signs of hypersensitivity or severe skin reactions promptly. Xbaren 150 Tablet SR should be prescribed and used under the supervision of a qualified healthcare professional.